SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001279569-24-000137
Filing Date
2024-02-13
Accepted
2024-02-13 07:01:41
Documents
16
Period of Report
2024-02-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 23022
5 NEWS RELEASE DATED FEBRUARY 13, 2024 ex991.htm EX-99.1 44381
6 GRAPHIC logo.jpg GRAPHIC 9119
  Complete submission text file 0001279569-24-000137.txt   263326

Data Files

Seq Description Document Type Size
2 XBRL LABEL FILE epix-20240213_lab.xml EX-101.LAB 34240
3 XBRL PRESENTATION FILE epix-20240213_pre.xml EX-101.PRE 22363
4 XBRL SCHEMA FILE epix-20240213.xsd EX-101.SCH 3021
18 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3703
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37410 | Film No.: 24622557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)